Biocronic’s Dengue NS1 Monoclonal Antibodies are developed for high sensitivity and specificity in the detection of NS1 antigen across all four dengue virus serotypes. Designed for ELISA and LFA platforms, these antibodies enable early-phase diagnosis and support reliable differentiation during acute dengue infection, aiding public health efforts in dengue-endemic regions.
Dengue NS1 Monoclonal Antibodies for Early & Accurate Detection
Detects NS1 antigens from all four dengue virus serotypes with high sensitivity - validated for ELISA & LFA platforms.
Product Overview
Product Data Table - needs to be updated
| Dengue | ||||||
| Cat No | Product Description | Type | Source | Platform | Application | COA |
| MDENAB101 | Specific for Dengue Type 1~4 antigen |
Dengue NS1 Antibody
|
LF | Detection | Download | |
| MDENAB204 | Specific for Dengue Type 1~4 antigen |
Dengue NS1 Antibody
|
LF | Detection | Download | |
| MDENAB307 | Specific for Dengue Type 1~4 antigen |
Dengue NS1 Antibody
|
LF | Capture | Download |
Key Features
High Sensitivity & Specificity
Enables accurate detection of NS1 antigen across all four dengue virus serotypes.
Assay Compatibility
Optimised for use in ELISA and Lateral Flow Assays (LFA).
Monoclonal Technology
Offers consistent binding performance and reliable batch-to-batch reproducibility.
Regulatory Compliance
Developed and manufactured in an ISO 13485-certified facility.